Desvignes C - Search Results

1

Panitumumab and cetuximab affect differently miRNA expression in colorectal cancer cells.

Chautard R, Corset L, Ibrahim S, Desvignes C, Paintaud G, Baroukh N, Guéguinou M, Lecomte T, Raoul W. Chautard R, et al. Among authors: desvignes c. Biomark Med. 2021 Jun;15(10):685-696. doi: 10.2217/bmm-2020-0520. Epub 2021 Jun 25. Biomark Med. 2021. PMID: 34169732

2

Pharmacokinetics of adalimumab in Crohn's disease.

Ternant D, Karmiris K, Vermeire S, Desvignes C, Azzopardi N, Bejan-Angoulvant T, van Assche G, Paintaud G. Ternant D, et al. Among authors: desvignes c. Eur J Clin Pharmacol. 2015 Sep;71(9):1155-7. doi: 10.1007/s00228-015-1892-1. Epub 2015 Jun 27. Eur J Clin Pharmacol. 2015. PMID: 26115613 Free article. No abstract available.

3

Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study.

Benhamou Y, Paintaud G, Azoulay E, Poullin P, Galicier L, Desvignes C, Baudel JL, Peltier J, Mira JP, Pène F, Presne C, Saheb S, Deligny C, Rousseau A, Féger F, Veyradier A, Coppo P; French Reference Center for Thrombotic Microangiopathies. Benhamou Y, et al. Among authors: desvignes c. Am J Hematol. 2016 Dec;91(12):1246-1251. doi: 10.1002/ajh.24559. Epub 2016 Nov 8. Am J Hematol. 2016. PMID: 27643485 Free article. Clinical Trial.

4

Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients.

Lioger B, Edupuganti SR, Mulleman D, Passot C, Desvignes C, Bejan-Angoulvant T, Thibault G, Gouilleux-Gruart V, Mélet J, Paintaud G, Ternant D. Lioger B, et al. Among authors: desvignes c. Br J Clin Pharmacol. 2017 Aug;83(8):1773-1781. doi: 10.1111/bcp.13270. Epub 2017 Apr 12. Br J Clin Pharmacol. 2017. PMID: 28230269 Free PMC article.

5

Immunoassays for Measuring Serum Concentrations of Monoclonal Antibodies and Anti-biopharmaceutical Antibodies in Patients.

Darrouzain F, Bian S, Desvignes C, Bris C, Watier H, Paintaud G, de Vries A. Darrouzain F, et al. Among authors: desvignes c. Ther Drug Monit. 2017 Aug;39(4):316-321. doi: 10.1097/FTD.0000000000000419. Ther Drug Monit. 2017. PMID: 28570370 Review.

6

Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti-TNF-α Antibodies after a Single Injection in Mice.

Arnoult C, Brachet G, Cadena Castaneda D, Azzopardi N, Passot C, Desvignes C, Paintaud G, Heuzé-Vourc'h N, Watier H, Gouilleux-Gruart V. Arnoult C, et al. Among authors: desvignes c. J Immunol. 2017 Jul 15;199(2):418-424. doi: 10.4049/jimmunol.1601246. Epub 2017 Jun 5. J Immunol. 2017. PMID: 28584008

7

Development and validation of an enzyme-linked immunosorbent assay to measure free eculizumab concentration in serum.

Passot C, Desvignes C, Ternant D, Bejan-Angoulvant T, Duveau AC, Gatault P, Paintaud G. Passot C, et al. Among authors: desvignes c. Bioanalysis. 2017 Aug;9(16):1227-1235. doi: 10.4155/bio-2017-0070. Epub 2017 Aug 2. Bioanalysis. 2017. PMID: 28766381

8

Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration.

Ternant D, Passot C, Aubourg A, Goupille P, Desvignes C, Picon L, Lecomte T, Mulleman D, Paintaud G. Ternant D, et al. Among authors: desvignes c. Clin Pharmacokinet. 2018 Sep;57(9):1173-1184. doi: 10.1007/s40262-017-0621-6. Clin Pharmacokinet. 2018. PMID: 29236229

9

Development and validation of an ELISA to study panitumumab pharmacokinetics.

Desvignes C, Passot C, Ternant D, Caulet M, Guérineau C, Lecomte T, Paintaud G. Desvignes C, et al. Bioanalysis. 2018 Feb;10(4):205-214. doi: 10.4155/bio-2016-0292. Epub 2018 Jan 18. Bioanalysis. 2018. PMID: 29345521

10

A successful compartmental approach for the treatment of breast cancer brain metastases.

Nguyen TT, Angeli E, Darrouzain F, Nguyen QT, Desvignes C, Rigal M, Nevine O, Nicolas P, Le QV, Winterman S, Pailler MC, Zelek L, Paintaud G, Janin A, Bousquet G. Nguyen TT, et al. Among authors: desvignes c. Cancer Chemother Pharmacol. 2019 Mar;83(3):573-580. doi: 10.1007/s00280-018-3752-z. Epub 2019 Jan 5. Cancer Chemother Pharmacol. 2019. PMID: 30610367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page